Show Summary Details
Page of

Drugs and breastfeeding in women with diabetes 

Drugs and breastfeeding in women with diabetes
Chapter:
Drugs and breastfeeding in women with diabetes
Author(s):

Denice S Feig

DOI:
10.1093/med/9780199593033.003.0055
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 23 October 2019

When prescribing drugs to a breastfeeding mother careful consideration of passage of drugs into breast milk and potential effects on the infant needs to be made

Of the oral hypoglycaemics metformin appears to pass into breast milk in only tiny quantities and can be considered for use, although caution is advised while nursing premature infants and those with renal impairment. More limited evidence supports use of selected sulphonylureas (glibenclamide, glipizide)

Antihypertensive agents commonly used in pregnancy (methyldopa, labetalol, nifedipine) can also be considered in breastfeeding mothers along with selected beta blockers and ACE inhibitors

Breastfeeding exerts many benefits for the mother and child and should be encouraged. Recent evidence suggests that there may be long-term benefits reducing the risk of obesity and type 2 diabetes in offspring.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.